Notably, EBV-positive HL cases often harbor fewer mutations in genes regulating the NF-κB pathway, such as TNFAIP3 and NFKBIA, due to the strong NF-κB activation. The gene discussed is NFKB1; the disease is Hodgkins lymphoma.